Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Binding of rifampicin by human plasma proteins.

Literature DB >> 4138537

Binding of rifampicin by human plasma proteins.

G Boman, V A Ringberger.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1974 PMID： 4138537 DOI： 10.1007/bf00558209

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

16 in total

1. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors: P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal: Clin Pharmacol Ther Date: 1970 Nov-Dec Impact factor: 6.875

2. Species differences in the plasma protein binding of desipramine.

Authors: O Borgå; D L Azarnoff; F Sjöqvist
Journal: J Pharm Pharmacol Date: 1968-07 Impact factor: 3.765

3. Detection of rifampicin binding immunoglobulins.

Authors: B S Nilsson; G Boman; W W Bullock
Journal: Scand J Respir Dis Suppl Date: 1973

4. Protein binding of rifampicin to different individual sera.

Authors: T Aoyagi
Journal: Scand J Respir Dis Suppl Date: 1973

5. Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.

Authors: G Boman
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

6. Species differences in the binding of phenylbutazone to plasma albumin.

Authors: C F Chignell; D K Starkweather
Journal: Pharmacology Date: 1971 Impact factor: 2.547

7. Physico-chemical studies on rifampicin.

Authors: J K Seydel
Journal: Antibiot Chemother Date: 1970

8. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors: M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal: Eur J Clin Pharmacol Date: 1971-09 Impact factor: 2.953

9. Rifampicin in plasma and pleural fluid after single oral doses.

Authors: G Boman; A S Malmborg
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

Review 10. Rifampicin, a general review.

Authors: G Binda; E Domenichini; A Gottardi; B Orlandi; E Ortelli; B Pacini; G Fowst
Journal: Arzneimittelforschung Date: 1971-12

22 in total

1. The management of tuberculous meningitis.

Authors: M Humphries
Journal: Thorax Date: 1992-08 Impact factor: 9.139

2. Protein Binding of First-Line Antituberculosis Drugs.

Authors: Wael A Alghamdi; Mohammad H Al-Shaer; Charles A Peloquin
Journal: Antimicrob Agents Chemother Date: 2018-06-26 Impact factor: 5.191

3. Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: adsorption of rifampicin by an excipient, bentonite.

Authors: G Boman; P Lundgren; G Stjernström
Journal: Eur J Clin Pharmacol Date: 1975-06-13 Impact factor: 2.953

Review 4. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors: W J Burman; K Gallicano; C Peloquin
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

Review 5. Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors: Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal: Expert Opin Pharmacother Date: 2009-02 Impact factor: 3.889

6. Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors: Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal: Antimicrob Agents Chemother Date: 2008-04-07 Impact factor: 5.191